Summary

Asia-Pacific inflation device market is expected to reach USD 298.73 million by 2032, from USD 185.86 million in 2024, growing at the CAGR of 6.1% in the forecast period of 2025 to 2032.
Market Segmentation:
Asia-Pacific inflation device market, By Type (Analog Inflation Device and Digital Inflation Device), Capacity (20ml Inflation Device, 25ml Inflation Device, 30ml Inflation Device, and 60ml Inflation Device), Application (Interventional Cardiology, Peripheral Vascular Procedures, Interventional Radiology, Urological Procedures, Gastroenterological Procedures, and Others), Pressure (30 atm, 40 atm, 55 atm, and Others), Function (Stent Deployment and Fluid Delivery), End User (Hospitals, Interventional Laboratories, and Clinics), Distribution Channel (Direct Tender, Retail Sales, and Third Party Distributors), Country (China, Japan, India, Australia, South Korea, Singapore, Thailand, Philippines, Malaysia, Indonesia, and rest of Asia-Pacific) – Industry Trends and Forecast to 2032
Overview of Asia-Pacific Inflation Device Market Dynamics:
Driver
• Rising case of cardiovascular diseases
Restraint
• High cost of advanced inflation devices
Opportunity
• Expanding access to interventional care in emerging markets
Market Players
The key market players for Asia-Pacific inflation device market are listed below:
• Boston Scientific Corporation
• BD
• Olympus Corporation
• Merit Medical Systems
• Medtronic
• Teleflex Incorporated
• CONMED Corporation
• Integra LifeSciences Corporation
• Vygon SAS
• Spectrum Medtech Pvt. Ltd
• Medorah Meditek Pvt. Ltd.
• SMT
• SURETECH MEDICAL INC.
• Cook
• Elite Medtek(Jiangsu) Co., Ltd
• Advin Health Care
• ADVANCED LIFESCIENCES PVT. LTD.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 INTRODUCTION 28
1.1 OBJECTIVES OF THE STUDY 28
1.2 MARKET DEFINITION 28
1.3 OVERVIEW OF THE ASIA-PACIFIC INFLATION DEVICE MARKET 28
1.4 LIMITATIONS 29
1.5 MARKETS COVERED 30
2 MARKET SEGMENTATION 32
2.1 MARKETS COVERED 32
2.2 GEOGRAPHICAL SCOPE 33
2.3 YEARS CONSIDERED FOR THE STUDY 34
2.4 CURRENCY AND PRICING 34
2.5 DBMR TRIPOD DATA VALIDATION MODEL 35
2.6 MULTIVARIATE MODELLING 38
2.7 TYPE LIFELINE CURVE 38
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 39
2.9 DBMR MARKET POSITION GRID 40
2.10 VENDOR SHARE ANALYSIS 41
2.11 MARKET END USER COVERAGE GRID 42
2.12 SECONDARY SOURCES 43
2.13 ASSUMPTIONS 43
3 EXECUTIVE SUMMARY 44
4 PREMIUM INSIGHTS 51
4.1 PESTAL ANALYSIS 52
4.2 COST ANALYSIS BREAKDOWN: ASIA-PACIFIC INFLATION DEVICE MARKET 53
4.3 HEALTHCARE ECONOMY 54
4.3.1 HEALTHCARE EXPENDITURE 54
4.3.2 CAPITAL EXPENDITURE (CAPEX) 54
4.3.3 CAPEX TRENDS 54
4.3.4 CAPEX ALLOCATION 54
4.3.5 FUNDING SOURCES 54
4.3.6 INDUSTRY BENCHMARKS 54
4.3.7 HEALTHCARE EXPENDITURE RATIO IN OVERALL GDP 54
4.3.8 HEALTHCARE SYSTEM STRUCTURE 55
4.3.9 GOVERNMENT POLICIES 55
4.3.10 ECONOMIC DEVELOPMENT 55
4.4 INDUSTRY INSIGHTS 56
4.5 PENETRATION AND GROWTH PROSPECT MAPPING: ASIA-PACIFIC INFLATION DEVICE MARKET 59
4.6 KEY PRICING STRATEGIES: ASIA-PACIFIC INFLATION DEVICE MARKET 61
4.7 INNOVATION TRACKER AND STRATEGIC ANALYSIS: ASIA-PACIFIC INFLATION DEVICE MARKET 63
4.8 OPPORTUNITY MAP ANALYSIS. 66
4.9 REIMBURSEMENT FRAMEWORK – ASIA-PACIFIC INFLATION DEVICE MARKET 68
4.10 DEFINITION AND IMPORTANCE OF TARIFFS IN THE HEALTHCARE SECTOR. 70
4.10.1 ASIA-PACIFIC VS. REGIONAL TARIFF STRUCTURES 70
4.10.2 IMPACT OF TARIFFS ON HEALTHCARE COSTS AND ACCESSIBILITY 70
4.10.3 TARIFF REGULATIONS IN KEY MARKETS 70
4.11 TARIFFS ON MEDICAL DEVICES & EQUIPMENT 71
4.11.1 IMPORT/EXPORT DUTIES ON MEDICAL EQUIPMENT 71
4.11.2 IMPACT ON PRICING AND AVAILABILITY OF HIGH-END MEDICAL TECHNOLOGY 71
4.11.3 CASE STUDIES OF TARIFF CHANGES AFFECTING THE INDUSTRY 71
4.11.4 COST BURDEN ON HOSPITALS AND HEALTHCARE FACILITIES 71
4.11.5 TARIFF EXEMPTIONS AND INCENTIVES 71
4.11.6 DUTY-FREE IMPORTS FOR ESSENTIAL MEDICINES AND VACCINES 71
4.11.7 IMPACT OF TRADE WARS ON THE HEALTHCARE SUPPLY CHAIN 71
4.11.8 ROLE OF FREE TRADE AGREEMENTS (FTAS) IN REDUCING TARIFFS 72
4.12 TECHNOLOGY ROADMAP: ASIA-PACIFIC INFLATION DEVICE MARKET 73
4.13 VALUE CHAIN ANALYSIS: ASIA-PACIFIC INFLATION DEVICE MARKET 74
5 REGULATORY COMPLIANCE: ASIA-PACIFIC INFLATION DEVICE MARKET 76
5.1 REGULATORY AUTHORITIES 76
5.2 REGULATORY SUBMISSIONS 77
5.3 INTERNATIONAL HARMONIZATION 77
5.4 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS 78
5.5 REGULATORY CHALLENGES AND STRATEGIES 78
6 MARKET OVERVIEW 79
6.1 DRIVERS 81
6.1.1 RISING CASE OF CARDIOVASCULAR DISEASES 81
6.1.2 WIDE RANGE OF APPLICATIONS OF INFLATION DEVICES 81
6.1.3 INCREASING NUMBER OF MINIMALLY INVASIVE SURGERIES 82
6.1.4 AGING POPULATION AND CHRONIC DISEASE BURDEN 82
6.2 RESTRAINTS 84
6.2.1 HIGH COST OF ADVANCED INFLATION DEVICES 84
6.2.2 MAINTENANCE AND TRAINING REQUIREMENTS 84
6.3 OPPORTUNITIES 85
6.3.1 EXPANDING ACCESS TO INTERVENTIONAL CARE IN EMERGING MARKETS 85
6.3.2 TECHNOLOGICAL ADVANCEMENTS IN INFLATION DEVICES 85
6.3.3 STRATEGIC PARTNERSHIPS AND ACQUISITIONS 86
6.4 CHALLENGES 87
6.4.1 LOW-COST ALTERNATIVES OF INFLATION DEVICES 87
6.4.2 SHORTAGE OF HEALTHCARE PROFESSIONALS LIMITING DEVICE UTILIZATION 87
7 ASIA-PACIFIC INFLATION DEVICE MARKET, BY TYPE 89
7.1 OVERVIEW 90
7.2 ANALOG INFLATION DEVICE 93
7.2.1 20ML INFLATION DEVICE 93
7.2.2 25ML INFLATION DEVICE 93
7.2.3 30ML INFLATION DEVICE 94
7.2.4 60ML INFLATION DEVICE 94
7.3 DIGITAL INFLATION DEVICE 94
7.3.1 30ML INFLATION DEVICE 95
7.3.2 25ML INFLATION DEVICE 95
7.3.3 20ML INFLATION DEVICE 95
7.3.4 60ML INFLATION DEVICE 95
8 ASIA-PACIFIC INFLATION DEVICE MARKET, BY CAPACITY 96
8.1 OVERVIEW 97
8.2 20ML INFLATION DEVICE 100
8.3 25ML INFLATION DEVICE 100
8.4 30ML INFLATION DEVICE 101
8.5 60ML INFLATION DEVICE 101
9 ASIA-PACIFIC INFLATION DEVICE MARKET, BY PRESSURE 102
9.1 OVERVIEW 103
9.2 30 ATM 106
9.3 40 ATM 106
9.4 55 ATM 107
9.5 OTHERS 107
10 ASIA-PACIFIC INFLATION DEVICE MARKET, BY APPLICATION 108
10.1 OVERVIEW 109
10.2 INTERVENTIONAL CARDIOLOGY 112
10.3 PERIPHERAL VASCULAR PROCEDURES 112
10.4 INTERVENTIONAL RADIOLOGY 113
10.5 UROLOGICAL PROCEDURES 113
10.6 GASTROENTEROLOGICAL PROCEDURES 114
10.7 OTHERS 114
11 ASIA-PACIFIC INFLATION DEVICE MARKET, BY DISTRIBUTION CHANNEL 115
11.1 OVERVIEW 116
11.2 DIRECT TENDER 119
11.3 RETAIL SALES 119
11.4 THIRD PARTY DISTRIBUTORS 120
12 ASIA-PACIFIC INFLATION DEVICE MARKET, BY END USER 121
12.1 OVERVIEW 122
12.2 HOSPITALS 125
12.3 INTERVENTIONAL LABORATORIES 125
12.4 CLINICS 126
13 ASIA-PACIFIC INFLATION DEVICE MARKET, BY FUNCTION 127
13.1 OVERVIEW 128
13.2 STENT DEPLOYMENT 131
13.3 FLUID DELIVERY 131
14 ASIA-PACIFIC INFLATION DEVICE MARKET, BY REGION 132
14.1 ASIA-PACIFIC 135
14.1.1 CHINA 139
14.1.2 JAPAN 142
14.1.3 INDIA 145
14.1.4 SOUTH KOREA 148
14.1.5 AUSTRALIA 151
14.1.6 SINGAPORE 154
14.1.7 MALAYSIA 157
14.1.8 INDONESIA 160
14.1.9 THAILAND 163
14.1.10 PHILIPPINES 166
14.1.11 REST OF ASIA-PACIFIC 169
15 ASIA-PACIFIC INFLATION DEVICE MARKET, COMPANY LANDSCAPE 170
15.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 170
16 SWOT ANALYSIS 171
17 COMPANY PROFILE 172
17.1 BOSTON SCIENTIFIC CORPORATION 172
17.1.1 COMPANY SNAPSHOT 172
17.1.2 REVENUE ANALYSIS 173
17.1.3 COMPANY SHARE ANALYSIS 173
17.1.4 PRODUCT PORTFOLIO 174
17.1.5 RECENT DEVELOPMENT 174
17.2 BD 175
17.2.1 COMPANY SNAPSHOT 175
17.2.2 REVENUE ANALYSIS 175
17.2.3 COMPANY SHARE ANALYSIS 176
17.2.4 PRODUCT PORTFOLIO 176
17.2.5 RECENT DEVELOPMENT 176
17.3 B. BRAUN INTERVENTIONAL SYSTEMS INC. 177
17.3.1 COMPANY SNAPSHOT 177
17.3.2 COMPANY SHARE ANALYSIS 177
17.3.3 PRODUCT PORTFOLIO 178
17.3.4 RECENT DEVELOPMENT 179
17.4 OLYMPUS CORPORATION 180
17.4.1 COMPANY SNAPSHOT 180
17.4.2 REVENUE ANALYSIS 180
17.4.3 COMPANY SHARE ANALYSIS 181
17.4.4 PRODUCT PORTFOLIO 181
17.4.5 RECENT DEVELOPMENT 182
17.5 MERIT MEDICAL SYSTEMS 183
17.5.1 COMPANY SNAPSHOT 183
17.5.2 REVENUE ANALYSIS 183
17.5.3 COMPANY SHARE ANALYSIS 184
17.5.4 PRODUCT PORTFOLIO 184
17.5.5 RECENT DEVELOPMENTS 185
17.6 ADVANCED LIFESCIENCES PVT. LTD. 186
17.6.1 COMPANY SNAPSHOT 186
17.6.2 PRODUCT PORTFOLIO 186
17.6.3 RECENT DEVELOPMENT 188
17.7 ADVIN HEALTH CARE 189
17.7.1 COMPANY SNAPSHOT 189
17.7.2 PRODUCT PORTFOLIO 189
17.7.3 RECENT DEVELOPMENT 189
17.8 ATRION MEDICAL 190
17.8.1 COMPANY SNAPSHOT 190
17.8.2 REVENUE ANALYSIS 190
17.8.3 PRODUCT PORTFOLIO 191
17.8.4 RECENT DEVELOPMENT 191
17.9 CONMED CORPORATION 192
17.9.1 COMPANY SNAPSHOT 192
17.9.2 REVENUE ANALYSIS 192
17.9.3 PRODUCT PORTFOLIO 193
17.9.4 RECENT DEVELOPMENT 193
17.10 COOK 194
17.10.1 COMPANY SNAPSHOT 194
17.10.2 PRODUCT PORTFOLIO 194
17.10.3 RECENT NEWS 194
17.11 ELITE MEDTEK(JIANGSU) CO., LTD 195
17.11.1 COMPANY SNAPSHOT 195
17.11.2 PRODUCT PORTFOLIO 195
17.11.3 RECENT DEVELOPMENT 195
17.12 INTEGRA LIFESCIENCES CORPORATION 196
17.12.1 COMPANY SNAPSHOT 196
17.12.2 REVENUE ANALYSIS 196
17.12.3 PRODUCT PORTFOLIO 197
17.12.4 RECENT DEVELOPMENT 198
17.13 MEDORAH MEDITEK PVT. LTD. 199
17.13.1 COMPANY SNAPSHOT 199
17.13.2 PRODUCT PORTFOLIO 199
17.13.3 RECENT DEVELOPMENT 199
17.14 MEDTRONIC 200
17.14.1 COMPANY SNAPSHOT 200
17.14.2 REVENUE ANALYSIS 200
17.14.3 PRODUCT PORTFOLIO 201
17.14.4 RECENT DEVELOPMENT 201
17.15 SMT 202
17.15.1 COMPANY SNAPSHOT 202
17.15.2 PRODUCT PORTFOLIO 202
17.15.3 RECENT DEVELOPMENT 202
17.16 SPECTRUM MEDTECH PVT. LTD. 203
17.16.1 COMPANY SNAPSHOT 203
17.16.2 PRODUCT PORTFOLIO 203
17.16.3 RECENT DEVELOPMENT 203
17.17 SURETECH MEDICAL INC. 204
17.17.1 COMPANY SNAPSHOT 204
17.17.2 PRODUCT PORTFOLIO 204
17.17.3 RECENT DEVELOPMENT 204
17.18 TELEFLEX INCORPORATED 205
17.18.1 COMPANY SNAPSHOT 205
17.18.2 REVENUE ANALYSIS 205
17.18.3 PRODUCT PORTFOLIO 206
17.18.4 RECENT DEVELOPMENT 206
17.19 US ENDOVASCULAR, LLC. 207
17.19.1 COMPANY SNAPSHOT 207
17.19.2 PRODUCT PORTFOLIO 207
17.19.3 RECENT DEVELOPMENT 208
17.20 VYGON SAS 209
17.20.1 COMPANY SNAPSHOT 209
17.20.2 PRODUCT PORTFOLIO 209
17.20.3 RECENT DEVELOPMENT 209
18 QUESTIONNAIRE 210
19 RELATED REPORTS 214